[PDF] Top 20 Everyday memory measures in multiple sclerosis: a systematic review

... Everyday memory refers to memory functions associated with daily ...of everyday memory have questionnaire items or activities that relate to, or closely resemble, routine ... See full document

... In the special article “Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis,” Rae-Grant et al. reported the findings of the Guideline ... See full document

... of Multiple Sclerosis (MS).We aimed to conduct a systematic review and meta-analysis to estimate a pooled odds ratio of developing MS by increasing age at ... See full document

... MS, multiple sclerosis; NPV, negative predictive value; PHQ-9, Patient Health Questionnaire; PPV, positive predictive value; PROMIS-D-8, Patient Reported Outcome Measurement Information System Depression ... See full document

... Multiple sclerosis (MS) is an inflammatory and autoimmune neurological disorder which leads to ...this review ranged from fair to ...This systematic review indicated that the probiotics ... See full document

... HIND, Daniel, KAKLAMANOU, Daphne, BEEVER, Dan, WEBSTER, Rosie, LEE, Ellen, BARKHAM, Michael and COOPER, Cindy L (2016). The assessment of depression in people with multiple sclerosis : a systematic ... See full document

... (Multiple Sclerosis Society, 2006). There is some suggestion that external memory aids may be effective in reducing everyday memory problems in people with MS (das Nair & Lincoln, ... See full document

... this review compared the use of CBT to a pharmacological intervention ...[58]. Systematic reviews suggest that the combination of CBT and antidepressant medication may be the most effective mode of ... See full document

... “Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of ... See full document

... MS, multiple sclerosis; NPV, negative predictive value; PHQ-9, Patient Health Questionnaire; PPV, positive predictive value; PROMIS-D-8, Patient Reported Outcome Measurement Information System Depression ... See full document

... We searched electronic papers published from 2000 to 30 August 2015. The search was conducted using international databanks including Web of Sciences, PubMed, Google Scholar, and Scopus. National databanks such as SID, ... See full document

... our systematic review we found suggestion that children had higher rates of body concern, depression, anx- iety, somatization, difficulty in relating to others and greater emotional and behavioural problems ... See full document

... We found evidence that combined extracts of THC and CBD may reduce symptoms of spasticity in patients with MS. Although the subjective experience of symptom reduction was generally found to be significant, objective ... See full document

... It is also possible that the relationship between the underlying biological mechanism of MS and depressive symptoms works in two directions. If that is the case, successful treatment of depression utilizing behavioral ... See full document

... This review has some ...initial review were excluded dues to language, their exclusion is likely to have biased data collection in favour of Western European ...this review; ... See full document

... MS, the most common cause of neurological disability among young adults, is generally believed to be a chronic inflammatory demyelinating disease, which has a median prevalence of 80/100,000 people in Europe. In- ... See full document

... Results: There is limited evidence of the effectiveness of four oral drugs for spasticity: baclofen, dantrolene, diazepam and tizanidine. Tizanidine appears to be no more effective than comparator drugs such as baclofen ... See full document

... behavioural memory intervention, the modified Story Memory ...a memory task within a widespread cortical network involving frontal and temporal regions; no significant changes were found in the ... See full document

... controlled trial). 146 (80%) participants were female; mean age (SD) was 48.6 (9.4) years. Relapsing remitting MS was the main diagnostic category (n = 123, 67%); 43 (26%) had secondary progressive disease; and the ... See full document

... of memory rehabilitation using different ...of memory rehabilitation, but the results obtained from randomised controlled trials (RCTs) and some systematic reviews have been less positive and ... See full document